SpineGuard Reports on its Extraordinary Shareholders Meeting held on 23 September 2021
23-September-2021 – 16h00 CE(S)TRead more
Annual Shareholders’ Meeting SpineGuard 9 June 2021
21-May-2021 – 08h00 CE(S)TRead more
Video SpineGuard and Carnot Interfaces (in french): quand la stratégie d’une PME des MedTech rencontre celle d’un laboratoire
Interview of Stéphane Bette, CEO of SpineGuard and Guillaume Morel, Director of Institut Tremplin Carnot - Professor of Sorbonne University - Director of ISIR (Sorbonne Université/CNRS/INSERM) regarding their partnership on robotics.Read more
SpineGuard’s scientific article “Robot-assisted spine surgery guided by conductivity sensing: first preclinical experiments demonstrate X-ray free breach detection”
Letter of innovation from CNRS on surgical robotic guidance in real time thanks to the DSG Technology
20-June-2019Read more - article in french
Interview of Stéphane Bette, SpineGuard’s CEO and Co-Founder, for DM magazine
SpineGuard: Riding robotic’s wave, from David Cassak, MedTech Strategist
Professor Yong QIU, Chairman of Orthopedic Surgery of Nanjing Drum Tower Hospital, performed the first surgery in China with the PediGuard® in spinal deformity.
18-April-2018Watch the video
How value-based spine care shapes technology development
Key thoughts on SpineGuard – featured article in Becker’s HealthcareRead more
Pierre Jerome, SpineGuard’s CEO and co-founder, was invited to speak at the Canaccord Genuity Musculoskeletal Conference in Orlando, Florida, on March 1, 2016
He shared SpineGuard’s vision during his presentation, where he says, “there is a real need for innovation and differentiation in the spine space where pedicle screws are used”. This presentation and the Q&A that followed was webcast live. A recording of the webcast can be accessed byVoir la vidéo
SpineGuard – Taming the Screw: Much of the innovation in spine over the past decade has aimed at replacing fusion, still the standard of care
SpineGuard’s novel sensor technology is betting on fusion’s long-term prospects, helping patients and surgeons by making the procedure safer.
Spineguard raised €8.1 million in Successful IPO (on NYSE Alternext), for growth, expansion and development.
SpineGuard (EPA:ALSGD) said its initial public offering on Europe’s Alternext exchange raised some €8.1 million, or roughly $10.5 million
The Paris-based medical device company makes the PediGuard device, designed to help guide the placement of pedicle screws during spinal fusion surgeries.Read more
SpineGuard raises $11 million and acquired PediGuard business unit from SpineVision, Inc.